[Development and preservation of specific T-cell immunity after COVID-19 or vaccination against this infection].

Unlabelled: Aim evaluation of specific T-cell immunity against SARS-CoV-2 in primary and secondary response to virus antigens by screening method.

Materials And Methods: Patients were tested 11.5 months after COVID-19 and 610 months before and after vaccination.

[Assesment of specific T-cell immunity to SARS-CoV-2 virus antigens in COVID-19 reconvalescents].

Introduction: The development of the COVID-19 pandemic has stimulated the scientific research aimed at studying of the mechanisms of formation the immunity against SARS-CoV-2. Currently, there is a need to develop a domestic simple and cost-effective specific method suitable for monitoring of T-cell response against SARS-CoV-2 in reconvalescents and vaccinated individuals.

Aim: Development of a screening method for evaluation specific T-cell immunity against SARS-CoV-2.